The authors of a guest editorial published by the American Botanical Council have proposed a regulatory structure for cannabis products that relies on federal support and coordination for state initiatives.
FDA said today it will have an update on a new regulatory structure for CBD by early fall. The announcement came via a press release on another warning issued to a CBD marketer making illegal disease claims.
Food complaints online in China, tighter controls of energy drink sales in the UK, and new research results on a patented citrus blend in Brazil—here’s a quick round-up of news from around the world:
With the increasing globalization of the supply chain, companies will have to look to their own in house capabilities to protect themselves and their consumers from contaminated products. That’s the essence of self regulation in any case.
The Council for Responsible Nutrition believes FDA has ample authority to regulate CBD in an expeditious manner, according to comments the trade organization filed on the federal docket this week.
The UK looks set to ban the sale of energy drinks high in caffeine to children after a Department of Health consultation lays bare the link to headaches, hyperactivity and obesity.
Industry-wide quality standards for identity and purity will be easier to agree upon than benchmarks for claims substantiation, according to the minutes of a recent stakeholders meeting.
FDA should issue targeted guidances to facilitate the filing of New Dietary Ingredient Notifications, according to comments filed by the American Herbal Products Association.
Belgium’s Federal Agency for Food Chain Safety (AFSCA) warns consumers to avoid the same curcumin-based supplement known to Italian authorities after the country also reports cases of acute cholestatic hepatitis.
A consultation process over Australia’s Country of Origin labelling rules is underway – the guidelines which came under scrutiny after a leading brand was refused permission to use ‘Made in Australia’ claims for products using imported fish oil.
The US market for foods and beverages featuring hemp-derived CBD – from relaxation drinks to gummies – could be worth $2.5bn by 2023, or 10.5% of an estimated $23.7bn market for CBD products (spanning everything from pharmaceuticals to petfood), predicts...
An interim final rule on CBD is a viable way for FDA to break the logjam on this increasingly popular ingredient, according to the head of one industry trade organization.
